EEE

Ernexa Therapeutics Inc.

No trades
Last report date
May 11, 2026
Report period
Q1 2026
Market capitalization
‪14.16 M‬USD
−30.72USD
‪−14.08 M‬USD
0.00USD
‪678.99 K‬
Beta (1Y)
2.73
Employees (FY)
5
Change (1Y)
−1 −16.67%
Revenue / Employee (1Y)
0.00USD
Net income / Employee (1Y)
‪−2.82 M‬USD

About Ernexa Therapeutics Inc.


CEO
Sanjeev Luther
Headquarters
Cambridge
Founded
1984
Identifiers
3
ISIN US1140824079
CFI code
ESVUFR
Ernexa Therapeutics, Inc. engages in the provision of cell engineering therapies. It is involved in the development of mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. The company was founded in 1984 and is headquartered in Cambridge, MA.

Check out other big names from the same industry as ERNA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently asked questions


The current price of ERNA is 9.56 USD — it has decreased by −21.25% in the past 24 hours. Watch Ernexa Therapeutics Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Ernexa Therapeutics Inc. stocks are traded under the ticker ERNA.
ERNA stock has risen by 37.36% compared to the previous week, the month change is a 91.20% rise, over the last year Ernexa Therapeutics Inc. has showed a −87.86% decrease.
We've gathered analysts' opinions on Ernexa Therapeutics Inc. future price: according to them, ERNA price has a max estimate of 30.00 USD and a min estimate of 30.00 USD. Watch ERNA chart and read a more detailed Ernexa Therapeutics Inc. stock forecast: see what analysts think of Ernexa Therapeutics Inc. and suggest that you do with its stocks.
ERNA reached its all-time high on Jun 23, 1993 with the price of 8,625,000.00 USD, and its all-time low was 3.18 USD and was reached on May 4, 2026. View more price dynamics on ERNA chart.
See other stocks reaching their highest and lowest prices.
ERNA stock is 26.99% volatile and has beta coefficient of 2.73. Track Ernexa Therapeutics Inc. stock price on the chart and check out the list of the most volatile stocks — is Ernexa Therapeutics Inc. there?
Today Ernexa Therapeutics Inc. has the market capitalization of ‪14.16 M‬, it has decreased by −1.88% over the last week.
Yes, you can track Ernexa Therapeutics Inc. financials in yearly and quarterly reports right on TradingView.
Ernexa Therapeutics Inc. is going to release the next earnings report on Aug 17, 2026. Keep track of upcoming events with our Earnings Calendar.
ERNA net income for the last quarter is ‪−5.51 M‬ USD, while the quarter before that showed ‪−1.50 M‬ USD of net income which accounts for 0.00% change. Track more Ernexa Therapeutics Inc. financial stats to get the full picture.
No, ERNA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 15, 2026, the company has 5 employees. See our rating of the largest employees — is Ernexa Therapeutics Inc. on this list?
Like other stocks, ERNA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Ernexa Therapeutics Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Ernexa Therapeutics Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Ernexa Therapeutics Inc. stock shows the sell signal. See more of Ernexa Therapeutics Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.